Read More Pharma Industry News Is the worst behind for Natural Capsules (NSE: NATCAPSUQ) after API delays and US tariff headwinds? Natural Capsules reports Q2FY26 loss amid US tariff pressure and API delays. Find out if its PLI benefits and expansion plans can turn the tide. byVenkateshNovember 14, 2025